Ovid Therapeutics Inc (OVID)

Official site

HEALTHCARE • BIOTECHNOLOGY • NASDAQ

$2.26

+0.07 (+3.20%)

Market Cap: $427.70M

Last updated: Oct 16, 2026 at 1:55 PM ET

Earnings

Performance (10Y)

Beat Rate

61%(23/38)

Avg Surprise

-0.74%

Streak

1 Q

Upcoming Estimates

Period ending Sep 30, 2026

EPS Consensus$-0.09

Range$-0.10 - $-0.08

8 analysts

EPS RevisionsNo revisions (7d)

30d

EPS Estimate DriftChange to current

90d ago$-0.11+16.0%

60d ago$-0.11+16.0%

30d ago$-0.09-0.2%

7d ago$-0.09-0.2%

Current$-0.09

Revenue Consensus

$28500

Range$0 - $200000

12 analysts

Period ending Dec 31, 2026

EPS Consensus$-0.08

Range$-0.11 - $-0.05

8 analysts

Revenue Consensus

$722420

Range$623170 - $2M

12 analysts

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$-0.08	$-0.11 - $-0.05	-	-	8	-	-
Sep 30, 2026Sep 26EST	-	$-0.09	$-0.10 - $-0.08	-	-	8	5 0 30d	-
Jun 30, 2026Jun 26 Reported Aug 13, 2026Reported Aug 13	$-0.08	$-0.10	$-0.12 - $-0.10	+20.00%	Beat	7	0 4 30d	-33.3%
Mar 31, 2026Mar 26 Reported May 12, 2026Reported May 12	$-0.12	$-0.11	$-0.15 - $-0.08	-9.09%	Miss	5	1 2 30d	+14.3%
Dec 31, 2025Dec 25 Reported Mar 18, 2026Reported Mar 18	$0.06	$-0.11	$-0.13 - $-0.11	+152.77%	Beat	5	1 1 30d	+146.2%
Sep 30, 2025Sep 25 Reported Nov 12, 2025Reported Nov 12	$-0.17	$-0.15	$-0.17 - $-0.13	-13.33%	Miss	5	0 2 30d	+15.0%
Jun 30, 2025Jun 25 Reported Aug 13, 2025Reported Aug 13	$-0.06	N/A	-	+60.00%	Beat	4	0 2 30d	-150.0%
Mar 31, 2025Mar 25 Reported May 13, 2025Reported May 13	$-0.14	$-0.13	$-0.13 - $-0.13	-7.69%	Miss	3	1 0 30d	+17.6%
Dec 31, 2024Dec 24 Reported Mar 11, 2025Reported Mar 11	$-0.13	$-0.17	$-0.19 - $-0.15	+22.20%	Beat	4	2 1 30d	+40.9%
Sep 30, 2024Sep 24 Reported Nov 12, 2024Reported Nov 12	$-0.20	$-0.23	$-0.29 - $-0.15	+13.04%	Beat	8	No revisions (30d)	-25.0%
Jun 30, 2024Jun 24 Reported Aug 13, 2024Reported Aug 13	$0.12	$-0.24	$-0.26 - $-0.12	+150.00%	Beat	9	No revisions (30d)	+166.7%
Mar 31, 2024Mar 24 Reported May 14, 2024Reported May 14	$-0.17	$-0.23	$-0.26 - $-0.17	+26.09%	Beat	8	0 1 30d	+10.5%
Dec 31, 2023Dec 23 Reported Mar 8, 2024Reported Mar 8	$-0.22	$-0.05	$-0.17 - $0.25	-340.00%	Miss	7	No revisions (30d)	-37.5%
Sep 30, 2023Sep 23 Reported Nov 3, 2023Reported Nov 3	$-0.16	$-0.19	$-0.20 - $-0.17	+15.79%	Beat	6	1 0 30d	+5.9%
Jun 30, 2023Jun 23 Reported Aug 4, 2023Reported Aug 4	$-0.18	$-0.21	$-0.22 - $-0.19	+14.29%	Beat	5	No revisions (30d)	+14.3%
Mar 31, 2023Mar 23 Reported May 5, 2023Reported May 5	$-0.19	$-0.17	$-0.18 - $-0.16	-11.76%	Miss	4	No revisions (30d)	+5.0%
Dec 31, 2022Dec 22 Reported Mar 13, 2023Reported Mar 13	$-0.16	$-0.18	$-0.19 - $-0.17	+11.11%	Beat	4	No revisions (30d)	-60.0%
Sep 30, 2022Sep 22 Reported Nov 8, 2022Reported Nov 8	$-0.17	$-0.21	$-0.23 - $-0.21	+19.05%	Beat	4	No revisions (30d)	+0.0%
Jun 30, 2022Jun 22 Reported Aug 9, 2022Reported Aug 9	$-0.21	$-0.25	$-0.25 - $-0.25	+16.00%	Beat	0	No revisions (30d)	+8.7%
Mar 31, 2022Mar 22 Reported May 10, 2022Reported May 10	$-0.20	$-0.21	$-0.22 - $-0.19	+4.76%	Beat	4	No revisions (30d)	-107.9%
Dec 31, 2021Dec 21 Reported Mar 15, 2022Reported Mar 15	$-0.10	$-0.16	$-0.17 - $-0.15	+37.50%	Beat	4	No revisions (30d)	+70.6%
Sep 30, 2021Sep 21 Reported Nov 10, 2021Reported Nov 10	$-0.17	$-0.18	$-0.21 - $-0.16	+5.56%	Beat	5	No revisions (30d)	+39.3%
Jun 30, 2021Jun 21 Reported Aug 16, 2021Reported Aug 16	$-0.23	$-0.16	$-0.19 - $-0.12	-43.75%	Miss	5	No revisions (30d)	+43.9%
Mar 31, 2021Mar 21 Reported May 13, 2021Reported May 13	$2.53	$1.13	$-0.25 - $2.87	+123.89%	Beat	6	No revisions (30d)	+783.8%
Dec 31, 2020Dec 20 Reported Mar 15, 2021Reported Mar 15	$-0.34	$-0.31	$-0.41 - $-0.10	-9.68%	Miss	7	1 0 30d	+2.9%
Sep 30, 2020Sep 20 Reported Nov 12, 2020Reported Nov 12	$-0.28	$-0.35	$-0.45 - $-0.05	+20.00%	Beat	7	No revisions (30d)	+34.9%
Jun 30, 2020Jun 20 Reported Aug 10, 2020Reported Aug 10	$-0.41	$-0.35	$-0.38 - $-0.27	-17.14%	Miss	7	No revisions (30d)	-20.6%
Mar 31, 2020Mar 20 Reported May 7, 2020Reported May 7	$-0.37	$-0.33	$-0.38 - $-0.25	-12.12%	Miss	8	No revisions (30d)	+19.6%
Dec 31, 2019Dec 19 Reported Mar 11, 2020Reported Mar 11	$-0.35	$-0.39	$-0.48 - $-0.34	+10.26%	Beat	8	No revisions (30d)	+32.7%
Sep 30, 2019Sep 19 Reported Nov 8, 2019Reported Nov 8	$-0.43	$-0.36	$-0.40 - $-0.34	-19.44%	Miss	8	No revisions (30d)	+18.9%
Jun 30, 2019Jun 19 Reported Aug 7, 2019Reported Aug 7	$-0.34	$-0.40	$-0.51 - $-0.35	+15.00%	Beat	7	No revisions (30d)	+35.8%
Mar 31, 2019Mar 19 Reported May 7, 2019Reported May 7	$-0.46	$-0.41	$-0.54 - $-0.31	-12.20%	Miss	7	No revisions (30d)	+14.8%
Dec 31, 2018Dec 18 Reported Mar 7, 2019Reported Mar 7	$-0.52	$-0.55	$-0.62 - $-0.44	+5.45%	Beat	7	No revisions (30d)	-15.6%
Sep 30, 2018Sep 18 Reported Nov 8, 2018Reported Nov 8	$-0.53	$-0.61	$-0.63 - $-0.55	+13.11%	Beat	5	No revisions (30d)	-39.5%
Jun 30, 2018Jun 18 Reported Aug 9, 2018Reported Aug 9	$-0.53	$-0.61	$-0.68 - $-0.55	+13.11%	Beat	6	1 0 30d	+7.0%
Mar 31, 2018Mar 18 Reported May 8, 2018Reported May 8	$-0.54	$-0.53	$-0.61 - $-0.41	-1.89%	Miss	6	2 0 30d	+84.5%
Dec 31, 2017Dec 17 Reported Mar 29, 2018Reported Mar 29	$-0.45	$-0.41	$-0.45 - $-0.38	-9.76%	Miss	5	No revisions (30d)	-
Sep 30, 2017Sep 17 Reported Nov 9, 2017Reported Nov 9	$-0.38	$-0.54	-	+29.63%	Beat	-	-	-
Jun 30, 2017Jun 17 Reported Aug 10, 2017Reported Aug 10	$-0.57	$-0.48	-	-18.75%	Miss	-	-	-
Mar 31, 2017Mar 17 Reported May 5, 2017Reported May 5	$-3.48	$-0.87	-	-300.00%	Miss	-	-	-

Key Metrics

Valuation
P/E Ratio	-7.29	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	0.00%	Operating Margin	-2101.00%
ROE	-26.00%	ROIC	N/A
Financial Health
Debt/Equity	0.00x	Interest Coverage	N/A
Current Ratio	12.39x	Quick Ratio	12.39x
Trading Statistics
Beta	0.23	Avg Volume	1.80M
52-Week High	$3.10	52-Week Low	$1.18

Technical Indicators Dashboard

Moving Averages

SMA 10$2.33

SMA 20$2.44

SMA 50$2.63

SMA 200$2.33

EMA 10$2.33

EMA 20$2.42

EMA 50$2.52

EMA 200$2.27

MACD

Line: -0.10Signal: -0.09Hist: -0.02

ADX

ADX: 22.9+DI: 16.1-DI: 31.0

Aroon & PSAR

Aroon Up32.0

Aroon Down96.0

PSAR$2.47

Bollinger Bands

Upper Band$2.76

Lower Band$2.13

%B Position2565%(Upper)

Band Width0.21

RSI (14-Day)

Neutral

38.0

Momentum Oscillators

Stoch %K18.3

Stoch %D18.9

Williams %R-67.0

ROC (10d)-7.0%

Momentum-0.17

CCI (20d)-113.9

MFI (14d)37.2

Volatility Measures

ATR (14d)$0.14(6.2%)

StdDev (20d)0.16

Hist Vol54.1%(High)

Volume Flow

VWAP$2.26

OBV186.2M

AD Line10.5M

CMF (20d)-0.083

Volume Metrics

Avg Vol (20d)1.8M

Vol Ratio0.7x

VWMA (20d)$2.49

Pivot Points

R3$2.43

R2$2.34

R1$2.27

Pivot Point$2.18

S1$2.10

S2$2.01

S3$1.94

Advanced Oscillators

TSI-24.12

Ultimate Osc42.1

KST-140.34

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$733,000	$0	$718,000	$132,000	$6.27M	$130,000	$76,000	$173,000	$169,000	$148,000	$142,000	$109,000
Cost of Revenue	$0	$0	$44,000	$0	$0	$0	N/A	$0	$0	$0	$401,392	$0
Gross Profit	$733,000	$0	$718,000	$132,000	$6.27M	$130,000	$76,000	$173,000	$169,000	$148,000	$142,000	$109,000

Operating Expenses	$16.43M	$17.85M	$13.01M	$12.65M	$11.35M	$12.68M	$10.80M	$13.40M	$20.69M	$17.57M	$18.33M	$12.14M
R&D	$9.96M	$11.18M	$6.59M	$5.87M	$6.46M	$6.66M	$5.93M	$7.86M	$12.58M	$10.40M	$10.64M	$5.33M
SG&A	$6.47M	$6.67M	$6.42M	$6.79M	$4.88M	$6.02M	$4.87M	$5.54M	$8.10M	$7.17M	$7.69M	$6.80M
Operating Income	$-15,698,000	$-17,846,000	$-12,293,000	$-12,523,000	$-5,073,000	$-12,550,000	$-10,725,000	$-13,226,000	$-20,517,000	$-17,417,000	$-18,188,000	$-12,029,000

Interest Income	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Interest Expense	$0	$0	$0	$0	$0	$0	$0	$780,000	$0	$0	$0	$0
Income Before Tax	$-15,009,000	$-16,988,000	$9.66M	$-12,158,000	$-4,684,000	$-10,235,000	$-9,254,000	$-14,006,000	$8.52M	$-11,694,000	$-15,322,000	$-11,253,000
Income Tax Expense	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0

Net Income	$-15,009,000	$-16,988,000	$9.66M	$-12,158,000	$-4,684,000	$-10,235,000	$-9,254,000	$-14,006,000	$8.52M	$-11,694,000	$-15,322,000	$-11,253,000

EBITDA	$-14,675,000	$-16,641,000	$9.99M	$-11,842,000	$-4,291,000	$-9,806,000	$-8,812,000	$-13,560,000	$8.94M	$-11,292,000	$-14,920,000	$-10,851,000
EBIT	$-15,009,000	$-16,988,000	$9.66M	$-12,158,000	$-4,684,000	$-10,235,000	$-9,254,000	$-14,006,000	$8.52M	$-11,694,000	$-15,321,000	$-11,253,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about OVID

News

OVID Initiates Coverage On Wolfe Research -- Rating Set to Outperform

Wolfe Research has initiated coverage on Ovid Therapeutics (OVID) with an "Outperform" rating and a $5.00 price target...

GuruFocus•Oct 15, 2026 9:12 AM ET10/15/26•Somewhat-Bearish

Ovid Therapeutics Initiated at Overweight by Cantor Fitzgerald

Cantor Fitzgerald has initiated coverage on Ovid Therapeutics (OVID) with an Overweight rating. This indicates a positive outlook from the firm regarding the pharmaceutical company's stock performance.

Moomoo•Oct 10, 2026 8:40 AM ET10/10/26•Bullish

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bausch Health Companies (BHC), Arvinas Holding Company (ARVN) and Ovid Therapeutics (OVID)

This article details analyst ratings for three healthcare companies: Bausch Health Companies (BHC), Arvinas Holding Company (ARVN)...

The Globe and Mail•Oct 9, 2026 3:40 PM ET10/9/26•Bullish

OVID Initiates Coverage by Guggenheim - Rating Set to Buy

Guggenheim has initiated coverage on Ovid Therapeutics Inc. (OVID) with a Buy rating and a price target of $7.00 per share...

GuruFocus•Oct 6, 2026 12:24 PM ET10/6/26•Somewhat-Bearish

Working capital per share of Ovid Therapeutics Inc. – HAN:1OT

This article focuses on the working capital per share for Ovid Therapeutics Inc. (HAN:1OT), listed on the Hannover Stock Exchange. It provides a snapshot of financial data...

TradingView•Sep 30, 2026 9:24 AM ET9/30/26•Neutral

OVID Valuation and Fair Value

P/E: -7.3x
Forward P/E: 1.8x
PEG: 0.0x
P/B: 2.1x

See GNG's fair value

OVID Profitability: Margins, ROIC and FCF

Operating margin: -2101.0%
Net margin: 0.0%
ROE: -26.0%
FCF margin: -3460.1%

OVID Competitors

Company	Ticker
Cross Country Healthcare Inc	CCRN
Zura Bio Limited Class A Ordinary Shares	ZURA
Prothena Corporation plc	PRTA
Community Health Systems Inc	CYH
Neuropace Inc	NPCE
Prenetics Global Ltd	PRE
Entera Bio Ltd	ENTX
DiaMedica Therapeutics Inc	DMAC

Sector: Healthcare

OVID Analyst Ratings

Consensus: Buy
Analysts: 10
Strong Buy: 0
Buy: 10
Hold: 0
Sell: 0
Strong Sell: 0

OVID Bull Case vs Bear Case

Bull case

100.0% of OVID's analyst ratings are Buy or Strong Buy.

Bear case

OVID's quarterly revenue changed -88.3% year over year.

OVID Earnings: Beat Rate and Next Report

Beat rate: 5 of 8 quarters (62.5%)
Average surprise: 29.7%
EPS estimate (fiscal period ending Sep 30, 2026): $-0.09
Estimate revisions (30 days, fiscal period ending Sep 30, 2026): 5 up, 0 down

Frequently Asked Questions About OVID

Does OVID pay dividends?

Ovid Therapeutics Inc (OVID) does not currently pay a regular dividend.

What is OVID's market cap?

Ovid Therapeutics Inc (OVID) has a market capitalization of $427.70M with a current stock price of $2.26.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In